- Embrace™ Neonatal MRI system is the First U.S. FDA approved MRI Designed for Neonatal Brain and Head Imaging in Neonatal Intensive Care Units (NICU)
PLEASANTON, Calif., Oct. 23, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it will be Aspect Imaging, Ltd.’s exclusive selling agent for the Embrace™ Neonatal MRI system in the United States. The Embrace™ Neonatal MRI System is designed specifically for imaging of the neonatal head. The Embrace™ Neonatal MRI System may be used on neonates with a head circumference up to 38 centimeters and weight between 1 and 4.5 kilograms. The system has a temperature-controlled incubator placed directly into the MRI system, minimizing movement of the baby. If urgent access to the baby is necessary during the imaging process, the baby can typically be removed from the system in less than 30 seconds.
The Embrace™ Neonatal MRI System can be placed inside a NICU environment because the system does not require a safety zone or a radiofrequency shielded room. Since the system is fully enclosed, medical device implants or any device in the NICU in close proximity to the system are not required to be “MR Conditional” or “MR Safe.”
"Natus is excited to partner with Aspect Imaging to bring this innovative MRI device to our NICU customers," said Jim Hawkins, President and Chief Executive Officer of Natus. "The Embrace™ MRI represents one of the most innovative products introduced into the NICU in the past several years as it significantly reduces risk associated with transporting fragile newborn babies."
In addition to its exclusive agency agreement, Natus will also gain equity participation in Aspect Imaging, Ltd.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
About Aspect Imaging
Aspect Imaging, Ltd. is a world leader in the design and development of complete, compact MRI and NMR systems. Their unique technology platform is the backbone for a wide range of products, spanning preclinical, medical, oil and gas, and advanced industrial markets. Advanced industrial applications include rheological analysis of both food products and industrial drilling mud with Aspect Imaging’s FlowscanTM. The AI-60 NMR is used for real-time, continuous flow-through stream analysis of dense and opaque materials such as crude oil, HF, and silicon production. For more information, visit www.aspectimaging.com.
COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President Finance and Chief Financial Officer
(925) 223-6700
[email protected]


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



